Compounds > butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide
Page last updated: 2024-08-26

butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide and a 65186

butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide has been researched along with a 65186 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Britton, DR; Cullen, MJ; Kerwin, JF; Kopecka, H; Nadzan, AM; Yahiro, L1

Other Studies

1 other study(ies) available for butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide and a 65186

ArticleYear
Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 34, Issue:4

    Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Motor Activity; Quinolines; Receptors, Cholecystokinin; Sincalide; Tetragastrin

1989